IndiaTickerLatest filing: SMS Pharmaceuticals Ltd - 532815 - Update on board meeting
ObservedCompany dossier
SMS Pharmaceuticals
NSE:SMSPHARMA · ISIN INE812G01025
- Close
- ₹396.65 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
SMS Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹173.4 Cr · PAT ₹18.2 Cr.
Exchange XBRLLatest ownership: promoter group 68.07% and public 31.93% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing SMS Pharmaceuticals Ltd - 532815 - Update on board meeting
BSE · exchange filing
Observed
Source filing SMS Pharmaceuticals Ltd - 532815 - Board Meeting Intimation for Approval Of Financial Results For The Quarter Ended 30Th June, 2026
BSE · financial results
Observed
Source filing SMS Pharmaceuticals Ltd - 532815 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Observed
Source filing SMS Pharmaceuticals Ltd - 532815 - Reminder Letter For Transfer Of Shares To Investor Education And Protection Fund (IEPF)
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹173.4 Cr
- Profit after tax
- ₹18.2 Cr
- EPS
- ₹2.15
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 68.07%
- Public
- 31.93%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL